Immunome Earnings
NASDAQ: IMNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.65
Immunome earnings summary
Immunome is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.65. In its most recent report on Aug 11, 2026 (Q2 2026), IMNM posted EPS of $-0.65. Revenue for the quarter was $0.
Across the last 16 reports, IMNM shares moved an average of 8.8% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
IMNM earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 11, 2026 | — | $-0.65 | — | +4.9% |
| May 12, 2026 | — | $-0.48 | — | +3.7% |
| Mar 3, 2026 | — | $-0.76 | — | -3.2% |
| Nov 6, 2025 | — | $-0.65 | — | +12.5% |
| Aug 6, 2025 | — | $-0.50 | — | +6.1% |
| May 12, 2025 | — | $-0.52 | — | +5.3% |
| Jan 29, 2025 | — | $-1.11 | — | -1.5% |
| Nov 13, 2024 | — | $-0.78 | — | -0.9% |
| Aug 12, 2024 | — | $-0.60 | — | +14.2% |
| May 14, 2024 | — | $-2.51 | — | +2.8% |
| Mar 28, 2024 | — | $-4.21 | — | -17.9% |
| Nov 9, 2023 | — | $-0.36 | — | -1.2% |
| Aug 9, 2023 | — | $-0.46 | — | -2.7% |
| May 5, 2023 | — | $-0.35 | — | +26.5% |
| Mar 16, 2023 | — | $-0.64 | — | -10.5% |
| Nov 14, 2022 | — | $-0.75 | — | +26.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.